New Alzheimer’s disease drug: Aducanamab’s clinical trials Joseph DuPree • November 2, 2022 Alzheimer’s disease is one of the most common causes of dementia worldwide and the population of individuals with the disease is projected to double by 2050. Alzheimer’s disease is a fatal disorder...
